Railroad, not sure about production yet, we'll know alot more after next shareholders meeting. I can only assume its ramping up based on a few things. 1. Orbimed deferred interest payments for two yrs. 2. Amgen production was slated to start this quarter. 3. Medimmune production started last quarter. 4. Management wants a rs now without filing for 6 month extension. Seems they are setting the stage for institutional/fund investors. Im curious as to the state of Abbvie/Sanofi/Hikma. Still a lot to find out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.